Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexis... by Ya-Wen Lin PhD, RN, Chun-Hsiang Lin MS, MD, Cheng-Li Lin MS, Che-Huei Lin PhD, BPhar, Ming-Hung Lin PhD, BPhar

Get full text

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial by Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS

Get full text